High bone turnover elevates the risk of denosumab-induced hypocalcemia in women with postmenopausal osteoporosis

Koji Ishikawa, Takashi Nagai, Keizo Sakamoto, +7

Therapeutics and Clinical Risk Management

Risk factors predicting osteosarcopenia in postmenopausal women with osteoporosis: A retrospective study

Hiroki Okamura, Koji Ishikawa, Yoshifumi Kudo, +11

PLoS ONE

Controlling nutritional status score predicts postoperative complications after hip fracture surgery

Toshio Yagi, Yusuke Oshita, Ichiro Okano, +4

BMC Geriatrics

Teriparatide Administration Increases Periprosthetic Bone Mineral Density After Total Knee Arthroplasty: A Prospective Study

Tatsuya Suzuki, Fumio Sukezaki, Takashi Shibuki, +3

The Journal of Arthroplasty

Bone HealthOsteoarthritisOrthopaedicsTotal Knee ArthroplastySurgery +7

A Novel Method for the Prediction of the Pedicle Screw Stability

Koji Ishikawa, Tomoaki Toyone, Toshiyuki Shirahata, +15

Clinical Spine Surgery A Spine Publication

The effect of denosumab on pedicle screw fixation: a prospective 2-year longitudinal study using finite element analysis

Soji Tani, Koji Ishikawa, Yoshifumi Kudo, +13

Journal of Orthopaedic Surgery and Research

Femur fracture during abdominal breech delivery

Shigeki Matsubara, Akio Izumi, Takashi Nagai, +2

Archives of Gynecology and Obstetrics

Skeletal TraumaOperative TreatmentFemur FractureTrauma SurgerySurgery +2

Type 1 diabetes patients have lower strength in femoral bone determined by quantitative computed tomography: A cross‐sectional study

Koji Ishikawa, Tomoyasu Fukui, Takashi Nagai, +5

Journal of Diabetes Investigation

Coumestrol as well as isoflavones in soybean extract prevent bone resorption in ovariectomized rats.

Shefang Ye, I Saga, Kimiko Ichimura, +3

PubMed

High bone turnover status as a risk factor in symptomatic hypocalcemia following denosumab treatment in a male patient with osteoporosis

Koji Ishikawa, Takashi Nagai, Koki Tsuchiya, +7

Clinical Interventions in Aging

Male PatientOsteoporosisBone DiseaseHuman Monoclonal AntibodyRisk Factor +14